CIRS Group Korea Selected as the Executing Agency for KCII's 2024 Global Cosmetic Licensing Consultation Support Project
Published: Author: Source: CIRS

On February 20, 2024, according to the announcement No. 2024-006 by the Korea Cosmetic Industry Institute (KCII), CIRS Group Korea, a subsidiary of CIRS Group, was designated as the executing agency for the KCII. CIRS Group Korea has been appointed as the designated service organization for the fifth consecutive year for the "Global Cosmetic Licensing Support Project," providing assistance to Korean cosmetic enterprises.

The support provided by the CIRS Group Korea as the executing agency for the KCII's 2024 Global Cosmetic Licensing Consultation Support Project includes:

  • United States- MoCRA: Review of product formulations and labelings;
  • EU- CPNP: Cosmetic Product Safety Report (CPSR) and Product Information File (PIF) & Responsible Person (RP) services; and
  • Japan- PMDA: Formulation reviews and experiments on hazardous substances.

About CIRS Korea

Established in November 2018, CIRS South Korea is considered an important milestone of CIRS Group’s global strategy. It devotes itself to providing global chemical regulation consultancy services, especially K-REACH compliance and product safety regulation consultancy services in South Korea. After four years of development, CIRS South Korea has become one of the top regulatory compliance consulting companies in South Korea, which, in return, further expands the businesses of CIRS Group in South Korea, and helps enhance the CIRS Group’s global market appeal.


We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.